Yoshihiro Akimoto

5.1k citations
158 papers · 3.9k indexed · h-index 35

Yoshihiro Akimoto

154 papers receiving 3.8k citations

Peers

Yoshihiro Akimoto
Comparison fields: 5 of 134
  • Immunology 965
  • Molecular Biology 2.2k
  • Cell Biology 509
  • Cancer Research 386
  • Nephrology 164
Replace Douglas J. Taatjes with:
Douglas J. Taatjes United States
Hiroshi Hirano Japan
Doug A. Brooks Australia
Hsinyu Lee Taiwan
John Yu United States
Jean‐Pierre Salles France
Ke Tang China
Stefania Mitola Italy
Koji Okamoto Japan
Yan Xu United States
Yoshihiro Akimoto relative to Douglas J. Taatjes United States Douglas J. Taatjes's profile →
Citations per field
00.5×1.5×
Douglas J. Taatjes · 1×
Citations per year

Countries citing papers authored by Yoshihiro Akimoto

Since Specialization
Citations

This map shows the geographic impact of Yoshihiro Akimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiro Akimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiro Akimoto more than expected).

Fields of papers citing papers by Yoshihiro Akimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshihiro Akimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiro Akimoto. The network helps show where Yoshihiro Akimoto may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yoshihiro Akimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yoshihiro Akimoto Line = papers co-authored together Yoshihiro Akimoto links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20235
3 202315
4 20235
5 20211
6 20209
7 202030
8 20201
9 201922
10 20198
11 201923
12 20162
13 20124
14 201132
15 201067
16 200819
17 200579
18 199826
19 199697
20 199214

About Yoshihiro Akimoto

Yoshihiro Akimoto is a scholar working on Immunology, Cell Biology and Immunology and Allergy, having authored 158 papers that have together received 3.9k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (42 papers), Galectins and Cancer Biology (26 papers), Carbohydrate Chemistry and Synthesis (19 papers), Pancreatic function and diabetes (14 papers), Skin and Cellular Biology Research (13 papers), Cell Adhesion Molecules Research (11 papers), Renal Diseases and Glomerulopathies (10 papers) and Reproductive System and Pregnancy (9 papers). The work is most often cited by research in Immunology (965 citations), Molecular Biology (2.2k citations) and Cell Biology (509 citations). Yoshihiro Akimoto has collaborated with scholars based in Japan, United States and Iran. Frequent co-authors include Hayato Kawakami, Hiroshi Hirano, Gerald W. Hart, Ryohei Yanoshita, Yuko Ogawa, Masami Kanai‐Azuma, Shinya Nagamatsu, Akiko Obinata, Mica Ohara‐Imaizumi and Sai Prasad N. Iyer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026